Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 230

1.

Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study.

Yap S, Boers GH, Wilcken B, Wilcken DE, Brenton DP, Lee PJ, Walter JH, Howard PM, Naughten ER.

Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):2080-5.

PMID:
11742888
[PubMed - indexed for MEDLINE]
Free Article
2.

Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.

Yap S, Naughten ER, Wilcken B, Wilcken DE, Boers GH.

Semin Thromb Hemost. 2000;26(3):335-40. Review.

PMID:
11011851
[PubMed - indexed for MEDLINE]
3.

B vitamins and homocysteine in cardiovascular disease and aging.

Wilcken DE, Wilcken B.

Ann N Y Acad Sci. 1998 Nov 20;854:361-70. Review.

PMID:
9928444
[PubMed - indexed for MEDLINE]
4.

Homocystinuria due to cystathionine beta-synthase deficiency--the effects of betaine treatment in pyridoxine-responsive patients.

Wilcken DE, Dudman NP, Tyrrell PA.

Metabolism. 1985 Dec;34(12):1115-21.

PMID:
3934499
[PubMed - indexed for MEDLINE]
5.

The natural history of vascular disease in homocystinuria and the effects of treatment.

Wilcken DE, Wilcken B.

J Inherit Metab Dis. 1997 Jun;20(2):295-300.

PMID:
9211201
[PubMed - indexed for MEDLINE]
6.

The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment.

Kluijtmans LA, Boers GH, Kraus JP, van den Heuvel LP, Cruysberg JR, Trijbels FJ, Blom HJ.

Am J Hum Genet. 1999 Jul;65(1):59-67.

PMID:
10364517
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The intellectual abilities of early-treated individuals with pyridoxine-nonresponsive homocystinuria due to cystathionine beta-synthase deficiency.

Yap S, Rushe H, Howard PM, Naughten ER.

J Inherit Metab Dis. 2001 Aug;24(4):437-47.

PMID:
11596648
[PubMed - indexed for MEDLINE]
8.

Relationship between homocysteine and superoxide dismutase in homocystinuria: possible relevance to cardiovascular risk.

Wilcken DE, Wang XL, Adachi T, Hara H, Duarte N, Green K, Wilcken B.

Arterioscler Thromb Vasc Biol. 2000 May;20(5):1199-202.

PMID:
10807733
[PubMed - indexed for MEDLINE]
Free Article
9.

Homocystinuria--the effects of betaine in the treatment of patients not responsive to pyridoxine.

Wilcken DE, Wilcken B, Dudman NP, Tyrrell PA.

N Engl J Med. 1983 Aug 25;309(8):448-53.

PMID:
6877313
[PubMed - indexed for MEDLINE]
10.

Homocystinuria due to cystathionine beta synthase deficiency.

Rao TN, Radhakrishna K, Mohana Rao TS, Guruprasad P, Ahmed K.

Indian J Dermatol Venereol Leprol. 2008 Jul-Aug;74(4):375-8.

PMID:
18797062
[PubMed - indexed for MEDLINE]
Free Article
11.

Novel risk factors for vascular disease: the homocysteine hypothesis of cardiovascular disease.

Wilcken DE.

J Cardiovasc Risk. 1998 Aug;5(4):217-21. Review.

PMID:
9919468
[PubMed - indexed for MEDLINE]
12.

Strategies for the treatment of cystathionine beta-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30 years.

Walter JH, Wraith JE, White FJ, Bridge C, Till J.

Eur J Pediatr. 1998 Apr;157 Suppl 2:S71-6.

PMID:
9587030
[PubMed - indexed for MEDLINE]
13.

Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology.

Dudman NP, Wilcken DE, Wang J, Lynch JF, Macey D, Lundberg P.

Arterioscler Thromb. 1993 Sep;13(9):1253-60.

PMID:
8364009
[PubMed - indexed for MEDLINE]
Free Article
14.

Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk.

Maclean KN, Jiang H, Greiner LS, Allen RH, Stabler SP.

Mol Genet Metab. 2012 Mar;105(3):395-403. doi: 10.1016/j.ymgme.2011.11.190. Epub 2011 Dec 2.

PMID:
22192524
[PubMed - indexed for MEDLINE]
15.

Classical homocystinuria: vascular risk and its prevention.

Yap S.

J Inherit Metab Dis. 2003;26(2-3):259-65. Review.

PMID:
12889665
[PubMed - indexed for MEDLINE]
16.

[Clinical picture of homocystinuria with cystathionine beta-synthase deficiency in 19 Czech and Slovak patients].

Orendác M, Kozich V, Zeman J, Hyánek J, Bzdúch V, Misovicová N, Marklová E, Vad'urová L, Pijácková A.

Cas Lek Cesk. 2000 Aug 16;139(16):500-7. Czech.

PMID:
11338767
[PubMed - indexed for MEDLINE]
17.

Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.

Vianna AC, Mocelin AJ, Matsuo T, Morais-Filho D, Largura A, Delfino VA, Soares AE, Matni AM.

Hemodial Int. 2007 Apr;11(2):210-6.

PMID:
17403173
[PubMed - indexed for MEDLINE]
18.

[A case report of pyridoxine-responsive homocystinuria].

Milosević-Tosić M, Borota J, Katanić D, Vlaski J.

Med Pregl. 1999 Nov-Dec;52(11-12):501-4. Croatian.

PMID:
10748775
[PubMed - indexed for MEDLINE]
19.

Homocystinuria due to cystathionine beta-synthase deficiency: novel biochemical findings and treatment efficacy.

Orendác M, Zeman J, Stabler SP, Allen RH, Kraus JP, Bodamer O, Stöckler-Ipsiroglu S, Kvasnicka J, Kozich V.

J Inherit Metab Dis. 2003;26(8):761-73.

PMID:
14739681
[PubMed - indexed for MEDLINE]
20.

Pediatric stroke among Hong Kong Chinese subjects.

Chung B, Wong V.

Pediatrics. 2004 Aug;114(2):e206-12.

PMID:
15286258
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk